Home
About Symray
Company Profile
Milestones
Management Team
Technology Platforms
Antibody Discovery Platform
Antibody Characterization Platform
Drug Validation Platform
Pipeline
Lead & Candidate Antibody Drugs
Hit Antibodies
External Collaboration
Collaboration Models
Partners
News
Join Us
Corporate Culture
Careers
Contact Us
中文
Home
About Symray
Company Profile
Milestones
Management Team
Technology Platforms
Pipeline
External Collaboration
Collaboration Models
Partners
News
Join Us
Corporate Culture
Careers
Contact Us
Pipeline
Home
Pipeline
Hit Antibodies
Lead & Candidate Antibody Drugs
Hit Antibodies
Indication
Solid tumors
Hematologic malignancies
Search
SY0023
PSMA
Solid tumors
SY0538
Mesothelin
Solid tumors
SY0625
FRA
Solid tumors
SY0828
IL-5Rα/CD125
Solid tumors
SY0831
Nectin-4
Solid tumors
SY0883
B7-H3/CD276
Solid tumors
SY1211
ROR1
Solid tumors
Hematologic malignancies
SY1274
DLL3
Solid tumors
SY1330
Not specified
Solid tumors
SY1556
LGR4
Solid tumors
SY1558
LILRB4/CD85k
Solid tumors
Hematologic malignancies
SY1600
LILRB1/CD85J
Solid tumors
Hematologic malignancies
SY1601
LILRB2/CD85D
Solid tumors
SY1604
FGFR4/CD334
Solid tumors
SY1606
FGFR2IIIb/CD332
Solid tumors
SY1700
TF/CD142
Solid tumors
1